Asked if there are plans of a family reorganisation, Apollo Hospitals group chief financial officer Krishnan Akhileswaran told ET, “No, there isn’t. It’s just a value unlock for shareholders. The promoters of Apollo will also be the promoters of the new company, and they will also be directors in the new company. So, there is no change from that standpoint.”
Double-digit growthApollo Hospitals, India’s largest pan-India hospital chain by revenue, announced its first quarter results post market hours on Tuesday. It posted a 42% on-year rise in first quarter consolidated net profit to ₹433 crore, driven by double-digit growth in all business segments.Revenues for the quarter grew 15% on-year to ₹5,842 crore, driven by higher patient volumes and growth in diagnostic footprint. The company saw 26% rise in earnings before interest, taxes, depreciation, and amortisation to ₹852 crore. It had earlier in the quarter announced spinning off its omni-channel pharmacy and digital health business into a new entity Apollo Healthtech.
CCI, NCLT nods”The application to the stock exchanges have been already made and once their approval is received, we can file to the CCI (Competition Commission of India) and NCLT (National Company Law Tribunal) simultaneously. We expect the listing to happen around January-March of 2027. Some of the NCLT-related approval should come much before that,” Akhileswaran elaborated.Apollo Hospitals Enterprise chairman Prathap C Reddy said, “The demerger of our digital health and pharmacy business, approved in the last quarter, is now in the implementation phase. This strategic move will enable focused capital allocation and sharper growth plans with dedicated management teams for both hospital operations and omnichannel healthcare ecosystem.”The hospital chain aims to add 4,370 beds through acquisition, brownfield and greenfield expansion over the next 3-4 years, with the first phase of 2,000 beds is already in progress. “Patient numbers across our network increased year-on-year. The quarter saw us announce our ambitious growth strategy to add over 4,300 beds in the next five years with an investment of over ₹7,600 crore,” said Dr Reddy.
